Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
MediGene Logo
MediGene Growth Score
64
CB Rank
172258
Heat Score
61
MediGene is a company that specializes in biotechnology specifically in the treatment of cancer.
Founded
obfuscation
PublicPost-IPO Equity Martinsried, Bayern, Germany51-100 www.medigene.com
Biotechnology
Health Care
Pharmaceutical
Therapeutics
Overview

MediGene
Total Funding
obfuscation
Growth Score
64
Heat Score
61

Total Funding
obfuscation
Post-IPO Equity raised
obfuscation
Growth Score64
-2 pts
in past quarter
Heat Score 61
-2 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
See more interactive data and historical milestones on desktop for the best experience

About MediGene

CB Rank
172258
MediGene is a company that specializes in biotechnology specifically in the treatment of cancer.
Founded
obfuscation
PublicPost-IPO Equity Martinsried, Bayern, Germany51-100 www.medigene.com
Biotechnology
Health Care
Pharmaceutical
Therapeutics

Funding Rounds

Post-IPO Equity
OBF
in
obfuscation
Post-IPO Equity
OBF
in
obfuscation
Post-IPO Equity
OBF
in
obfuscation

Key People

  • Photo of Pamela Keck
    Pamela Keck: Vice President of Investor Relations and Corporate Communications
  • Photo of James Noble
    James Noble: Non Executive Director
    Past Role: Immunocore, Part Time CEO

Details

Legal Name Medigene AG
Operating Status Active
Stock Symbol  ETR:MDG1
Company Type For Profit
Founders  Horst Domdey
About the Company
MediGene is a company that specializes in biotechnology specifically in the treatment of cancer.
Phone Number +49-89-20 00 33 - 29 20
Contact Email medigene@medigene.com
Predictions & Insights

Growth Insight

See this Growth Insight
MediGene is
Lorem
 to be growing
Top Contributing Factors
Recently Raised Funding

Products & Services

End-to-End Platform
A comprehensive platform for developing T cell receptor (TCR)-guided therapies, including TCR-T, TCR-T cell engagers, and TCR-natural killer cell therapies, focusing on specificity, sensitivity, and safety.
MDG1015
A third-generation TCR-T therapy targeting NY-ESO-1/LAGE-1a, incorporating a PD1-41BB costimulatory switch protein to enhance T cell function in solid tumors.

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials

Company Funding

Total Funding Amount 
obfuscation
Number of Funding Rounds 5
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Post-IPO Equity - MediGene Logo
Post-IPO Equity - MediGene
—
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - MediGene Logo
Post-IPO Equity - MediGene
—
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - MediGene Logo
Post-IPO Equity - MediGene
—
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - MediGene Logo
Post-IPO Equity - MediGene
—
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - MediGene Logo
Post-IPO Equity - MediGene
—
obfuscation
— Post-IPO Equity

Funding Rounds

Total Funding Amount 
obfuscation
Number of Funding Rounds 5
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Post-IPO Equity - MediGene Logo
Post-IPO Equity - MediGene
—
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - MediGene Logo
Post-IPO Equity - MediGene
—
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - MediGene Logo
Post-IPO Equity - MediGene
—
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - MediGene Logo
Post-IPO Equity - MediGene
—
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - MediGene Logo
Post-IPO Equity - MediGene
—
obfuscation
— Post-IPO Equity

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.
Investor Name  
Lead Investor  
Funding Round  
Partners  
BioNTech Logo
BioNTech
Yes
Post-IPO Equity - MediGene Logo
Post-IPO Equity - MediGene
Ugur Sahin
BioNTech Logo
BioNTech
Yes
Post-IPO Equity - MediGene Logo
Post-IPO Equity - MediGene
Ugur Sahin
BioNTech Logo
BioNTech
Yes
Post-IPO Equity - MediGene Logo
Post-IPO Equity - MediGene
Ugur Sahin
BioNTech Logo
BioNTech
Yes
Post-IPO Equity - MediGene Logo
Post-IPO Equity - MediGene
Ugur Sahin
BioNTech Logo
BioNTech
Yes
Post-IPO Equity - MediGene Logo
Post-IPO Equity - MediGene
Ugur Sahin

Investments

Number of Investments 1
Number of Acquisitions 1
See investment data for this company, with details on deal size, industry, stage, and more.
Announced Date  
Organization Name  
Lead Investor  
Funding Round  
Money Raised  
obfuscation
leon nanodrugs Logo
leon nanodrugs
—
Series A - leon nanodrugs Logo
Series A - leon nanodrugs
obfuscation
obfuscation
leon nanodrugs Logo
leon nanodrugs
—
Series A - leon nanodrugs Logo
Series A - leon nanodrugs
obfuscation
obfuscation
leon nanodrugs Logo
leon nanodrugs
—
Series A - leon nanodrugs Logo
Series A - leon nanodrugs
obfuscation
obfuscation
leon nanodrugs Logo
leon nanodrugs
—
Series A - leon nanodrugs Logo
Series A - leon nanodrugs
obfuscation
obfuscation
leon nanodrugs Logo
leon nanodrugs
—
Series A - leon nanodrugs Logo
Series A - leon nanodrugs
obfuscation

Investment Breakdown

Number of Investments 1
Number of Acquisitions 1
See investment data for this company, with details on deal size, industry, stage, and more.
Announced Date  
Organization Name  
Lead Investor  
Funding Round  
Money Raised  
obfuscation
leon nanodrugs Logo
leon nanodrugs
—
Series A - leon nanodrugs Logo
Series A - leon nanodrugs
obfuscation
obfuscation
leon nanodrugs Logo
leon nanodrugs
—
Series A - leon nanodrugs Logo
Series A - leon nanodrugs
obfuscation
obfuscation
leon nanodrugs Logo
leon nanodrugs
—
Series A - leon nanodrugs Logo
Series A - leon nanodrugs
obfuscation
obfuscation
leon nanodrugs Logo
leon nanodrugs
—
Series A - leon nanodrugs Logo
Series A - leon nanodrugs
obfuscation
obfuscation
leon nanodrugs Logo
leon nanodrugs
—
Series A - leon nanodrugs Logo
Series A - leon nanodrugs
obfuscation
Market Intelligence
People
View Profiles & Contacts
Headcount 51-100 Employee Profiles 4 Board Members and Advisors 1 Contacts 12

Employee Profiles

Board Members and Advisors

News

News and Press

News•Aug 5, 2025
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Jul 22, 2025
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•May 28, 2025
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Apr 22, 2025
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
Access a complete feed of recent news and press, from product launches to leadership changes.
Technology
View Tech Report

Monthly Web Visits

560
-13.71%
 in past month

IT Spend

$734.8KThis year, MediGene is projected to spend $734.8K on IT, according to Aberdeen.

Interest Signals

TopicSurge Score
Email Campaigns Logo
Email Campaigns
79
Email Campaign Logo
Email Campaign
79
Code Search Logo
Code Search
65

Actively Used Products

16MediGene uses 16 technology products and services including HTML5, Lightbox, and  F5 NGINX, according to G2 Stack.

Active Website Tech Count

14MediGene is actively using 14 technologies for its website, according to BuiltWith. These include SSL by Default, HSTS, and  DNSSEC.

Total IP

38The intellectual property of MediGene includes 29 registered patents primarily in the 'Medical Or Veterinary Science; Hygiene' category, according to IPqwery. Additionally, MediGene has registered 9 trademarks with the most popular class being 'Pharmaceutical, veterinary and sanitary products', according to IPqwery.
Sub-Organizations
Frequently Asked Questions

Where is MediGene's headquarters? MediGene is located in Martinsried, Bayern, Germany.Who invested in MediGene? MediGene has 2 investors including BioNTech and  Techno Venture Management.When was the last funding round for MediGene? MediGene closed its last funding round on
obfuscation
from a Post-IPO Equity round.How much funding has MediGene raised to date? MediGene has raised
obfuscation
.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(55a1db1 1)
|